• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
GUO Qianqian. Advances in the research of paclitaxel nanoliposomes[J]. Journal of China Pharmaceutical University, 2014, 45(5): 599-606. DOI: 10.11665/j.issn.1000-5048.20140517
Citation: GUO Qianqian. Advances in the research of paclitaxel nanoliposomes[J]. Journal of China Pharmaceutical University, 2014, 45(5): 599-606. DOI: 10.11665/j.issn.1000-5048.20140517
shu

Advances in the research of paclitaxel nanoliposomes

More Information
    Graphical Abstract
    • Abstract
  • With their antitumor advantages, paclitaxel nanoliposomes have been widely used in clinical treatment. Numerous works on paclitaxel nanoliposomes have been studied and have made great progress. This paper discusses the ways to improve the solubility of paclitaxel, to improve the targeting of nanoliposomes, and to optimize its preparation conditions, with also a prospect of the future development of paclitaxel nanoliposomes.
    • FullText(HTML)
    • References (56)
  • [1]
    Utreja P, Jain S, Tiwary AK.玈 Localized delivery of paclitaxel using elastic liposomes formulation development and evaluation[J]. Drug Deliv,2011,18(5):367-376.
    [2]
    Guo T,Sun FD,Gao SC,et al.Study on 2-hydroxpropyl-β-cyclodextrin paclitaxel inclusion compound[J].China Pharm(中国药师),2012,15(1):3-6.
    [3]
    Huo MR,Zhang Y,Zhou JP,et al.Preparation of paclitaxel-loaded chitosan self-assembled nanomicelles freeze-dried powder for injection and its physicochemical characterization[J].Chin Pharm J(中国药学杂志),2009,44(3):199-204.
    [4]
    Tian H,Jin YH,Chen YJ,et al.Modification of taxol with amino acids derivatives of polyethylene glycol[J].J China Pharm Univ(中国药科大学学报),2011,42(1):78-82.
    [5]
    Liu W,Guo T,Ge JW,et al.An oligopeptide improves solubility of paclitaxel by non-covalent interaction[J].Acta Pharm Sin(药学学报),2012,47(7):947-952.
    [6]
    Wang J,Huo MR,Zhou JP,et al.Drugs-loaded micelles based on hyaluronic acid-paclitaxel prodrug:preparation and pharmacokinetic study in rats[J].J China Pharm Univ(中国药科大学学报),2013,44(6):520-525.
    [7]
    Sun J, Ju CY, Zhang C. Preparation and anti-tumor activity of paclitaxel thermo-sensitive hydrogel[J].J China Pharm Univ(中国药科大学学报),2012,43(5):424-429.
    [8]
    Mo QQ, Chen PB, Jin X, et al. Inhibition of Hecl expression enhances the sensitivity of human ovarian cancer cells to paclitaxel[J].Acta Pharmacol Sin(中国药理学报),2013,34(4):541-548.
    [9]
    Zhou J,Zhao WY,Ma X,et al. The anticancer efficacy of paclitaxel liposomes modified with mitochondrial targeting conjugate in resistant lung cancer[J].Biomaterials,2013,34(14):3 626-3 638.
    [10]
    Liu SL,Liu SY,Zhang HH.Study on the preparation of paclitaxel liposome and the tropism for the brain targeted therapy[J].China J Hosp Pharm(中国医院药学杂志),2012,32(24):1 979-1 983.
    [11]
    Wang X,Song L,Li N,et al.Pharmacokinetics and biodistribution study of paclitaxel liposome in Sprague-Dawley rats and Beagle dogs by liquid chromatography-tandem mass spectrometry[J]. Drug Res,2013,63(11):603-606.
    [12]
    Liu YJ,Liu CX,Li M,et al.Polymer-polymer conjugation to fabricate multi-block polymer as novel drug carriers:poly(lactic acid)-poly(ethylene glycol)-poly(l-lysine)to enhance paclitaxel target delivery[J]. J Biomed Nanotechnol,2014,10(6):948-958.
    [13]
    Wang YF,Chang ZF,Wang H,et al.Immunosuppressive effect of paclitaxel liposome on B lymphocytes[J].Chin New Drugs J(中国新药杂志),2009,18(24):2 345-2 348.
    [14]
    Zhao JG,Wang JF,Wu DP,et al.Clinical observation of paclitaxel liposome combined with capecitabine in the first-line treatment of advanced gastric cancer[J].J China Pharm(中国药房),2010,21(14):1 313-1 315.
    [15]
    Suo T,Ge W,Zhang JZ,et al.17 cases of advanced non-small cell lung cancer treated with paclitaxel liposome plus nedaplatin[J].Chin Ger J Clin Oncol,2012,11(4):196-198.
    [16]
    Zhou CC,Meng SY,Zhou W,et al.A dual targeting tumor paclitaxel nanoliposome and its preparation method:CN,102166190A[P].2011-08-31[2014-04-24]
    [17]
    Luo LM,Huang Y,Zhao BX,et al.Anti-tumor and anti-angiogenic effect of metronomic cyclic NGR-modified liposomes containing paclitaxel[J]. Biomaterials,2013,34(4):1 102-1 114.
    [18]
    Meng SY,Su B,Li W,et al.Integrin-targeted paclitaxel nanoliposomes for tumor therapy [J].Med Oncol,2011,28(4):1 180-1 187.
    [19]
    Liang Q,Liang L,Han JW,et al.One kind of immune nanoliposomes paclitaxel and its preparation method and uses:CN,102379848 A[P].2012-03-21[2014-04-24]
    [20]
    Zhao M,Chang J,Fu XP,et al.Nano-sized cationic polymeric magnetic liposomes significantly improves drug delivery to the brain in rats [J].J Drug Target,2012,20(5):416-421.
    [21]
    Xin SC,Wu XR,Zhou LZ.Preparation of magnetic solid liposome nanoparticles of paclitaxel[J].Acta Pharm Sin(药学学报),2006,41(10):933-938.
    [22]
    Qian XZ,Xu YL,Han WY,et al.One kind of folic acid-carboxymethyl chitosan modified pH sensitive nanoliposome to paclitaxel:CN,102488658A[P].2012-06-13[2014-04-24]
    [23]
    Li Q,Li M,Jin GY,et al.Preparation and in vitro anti-cancer effect of paclitaxel-loaded pH-sensitive block copolymer micelles[J].J Int Pharm Res,2013,40(2):233-241.
    [24]
    Xu D,Gong W,Liu N,et al.Quantification of paclitaxel in rat plasma by LC-MS/MS and pharmacokinetics of paclitaxel thermosensitive liposomes in rats[J].Chin Pharm J(中国药学杂志),2012,47(22):1 839-1 843.
    [25]
    Shen ZT,Yang N,Yu LX,et al.The LD50 and difference of paclitaxel and docetaxel thermosensitive nano-micelle[J].Jiangsu Med J(江苏医药),2008,34(1):56-58.
    [26]
    Nie S,Hsiao WL,Pan W,et al.Thermoreversible Pluronic F127-based hydrogel containing liposomes for the controlled delivery of paclitaxel: in vitro drug release,cell cytotoxicity,and uptake studies[J].Int J Nanomed,2011,6:151-166.
    [27]
    Zhang YY,Fu XD,Liu KD,et al.Preparation and tumor targeting of NGR-SWCNTs-paclitaxel[J].Chin Pharm J(中国药学杂志),2013,48(20):1 748-1 754.
    [28]
    Shvedova AA,Castranova V,Kisin ER,et al.Exposure to carbon nanotube material:assessment of nanotube cytotoxicity using human keratinocyte cells[J].J Toxicol Environ Health A,2003,66(20):1 909-1 926.
    [29]
    Huo MR,Zhou JP,Wei Y,et al.Preparation of paclitaxel loaded cationic chitosan micelles and study of its biodistribution in mice[J].J China Pharm Univ(中国药科大学学报),2006,37(2):132-136.
    [30]
    Ji DY,Wu QZ,Ping QN.Synthesis of PLA-mPEG and preparation of docetaxel of polymer micelles[J].J China Pharm Univ(中国药科大学学报),2008,39(3):223-227.
    [31]
    Tan Y,Zhou JP,Tong XY,et al.Pharmacokinetics of F-68 modified paclitaxel liposomes in rats[J].J China Pharm Univ(中国药科大学学报),2006,37(3):230-232.
    [32]
    Li WT,Wang L,Zhang C.Influence of surface characteristics on hepatocellular carcinoma cells uptake of nano-liposomes[J].J China Pharm Univ(中国药科大学学报),2013,44(3):244-248.
    [33]
    Li SB,Liu D,Ning H,et al.Determination of entrapment efficiency of paclitaxel solid lipid nanoparticles[J].Chin Pharm J(中国药学杂志),2008,43(21):1 665-1 668.
    [34]
    Zhang L,Li YH,Wang CX,et al.Preparation of liposomal paclitaxel and its toxicity and antitumor effect[J].Chin Pharm J(中国药学杂志),2013,48(6):446-449.
    [35]
    Zhong C,Xiu LY;Yu SJ,et al.Modulation of release of paclitaxel from composite cerasomes[J]. Colloids Surf B Biointerfaces,2012,98:97-104.
    [36]
    Wang SJ,Hou W,Sun K,et al.Effects of several auxiliary materials on the particle size and Zeta potential of paclitaxel liposome[J]. Med Plant,2011,2(10):52-55.
    [37]
    Mei L,Song CX,Jin X,et al.Surface modified paclitaxel loaded nanoparticles as local delivery system for the prevention of vessel restenosis[J].Acta Pharm Sin(药学学报),2007,42(1):81-86.
    [38]
    Liu D,Li SB,Bao J,et al.Preparation in vitro release and pharmacokinetics of paclitaxel lipid nanoparticles for intravenous injection[J].Chin Pharm J(中国药学杂志),2009,44(17):1 320-1 326.
    [39]
    Ma YL,Ye J,Zhang PX,et al.Comparative study on pharmacokinetics and tissue distribution of a novel microemulsion based on the paclitaxel/L-OH lipid complex and paclitaxel injection in cremophor[J].Acta Pharma Sin(药学学报),2013,48(11):1 698-1 704.
    [40]
    Li XM,Cheng XD,Wang YL,et al.Prepatation of paclitaxel nanosuspension and study of its pharm acokinetic and biodistribution behavior in rats[J].Chin Pharm J(中国药学杂志),2011,46(9):680-685.
    [41]
    Tang Y,Li J,Zhang YD.Anticancer effect of long-circulating nanoliposome packaging paclitaxel in vitro and in vivo[J].China J Mod Med(中国现代医学杂志),2012,22(10):29-32.
    [42]
    Meng SY,Zhou CC,Su B,et al.Preparation and characterization of PEGylated paclitaxel liposomes[J].Prog Mod Biomed(现代医学生物进展)2009,9(13):2 407-2 409.
    [43]
    Yan F,Li L,Deng ZT,et al.Paclitaxel-liposome-microbubble complexes as ultrasound-triggered therapeutic drug delivery carriers[J].J Control Release,2013,166(3):246-255.
    [44]
    Patel NR,Rathi A,Mongayt D,et al.Reversal of multidrug resistance by co-delivery of tariquidar(XR9576)andpaclitaxel using long-circulating liposomes[J].Int J Pharm,2011,416(1):296-299.
    [45]
    Gao L,Liu GY,Ma JL,et al.Studies on pharmacokinetices and acute toxieity of paclitaxel nanosuspensions[C].Beijing:2012 Chinese Pharmaceutical Conference Abstract,2013:277-281.
    [46]
    Ji XF,Gao Y,Chen LL,et al.Nanohybrid systems of non-ionic surfactant inserting liposomes loading paclitaxel for reversal of multidrug resistance[J].Int J Pharm,2012,422(1/2):390-397.
    [47]
    Xu C, Jiang SG, Gong XF, et al. Nano-paclitaxel transport by human intestinal epithelial Caco-2 cells[J]. Bull Botanical Res,2013,33( 3):339-345.
    [48]
    Cui YN, Ge JJ, Li LB. Preparation of paclitaxel-loaded mixed micelles and enhancement on oral absorption of paclitaxel[J].J Shandong Univ(Health Sci)(山东大学学报 医学版),2012,50(11):107-112.
    [49]
    Li CC,Zhang ZH,Zhang YL,et al.In situ rat intestine absorption of paclitaxel-loaded solid lipid nanoparticles modified with cell-penetrating peptides[J].Acta Pharma Sin(药学学报),2013,48(1):131-137.
    [50]
    Peng L,Kong Y,Liu SJ,et al.A rapid liquid chromatography-tandem mass spectrometry method for determination of paclitaxel in plasma[J].Chin Hosp Pharm J(中国医院药学杂志),2013,33(20):1 682-1 685.
    [51]
    Ye DM,Chen XY,Lan S.Comparison of liver injury degree in mice induced by 6 kinds of com mon antineoplastic drugs[J].J China Pharm(中国药房),2011,22(29):2 720-2 722.
    [52]
    Solomon MA, Shah AA, D′Souza GG. In vitro assessment of the utility of stearyl triphenyl phosphonium modified liposomes in overcoming the resistance of ovarian carcinoma Ovcar-3 cells to paclitaxel [J]. Mitochondrion,2013,13(5):464-472.
    [53]
    Yan Z,Xia LP,Qiu HJ,et al.Short-term outcomes of albumin-bound paclitaxel(abraxane)-containing chemotherapy in patients with advanced gastric cancer:a report of 14 cases[J].Chin Ger J Clin Oncol,2013,12(1):30-34.
    [54]
    Shao JC,Lin HX,Cui YM,et al.Design,synthesis and evaluation of the cytotoxicity of a N-mustard and paclitaxel conjugate prodrug [J].J Chin Pharm Sci(中国药学),2013,22(2):137-143.
    [55]
    Zhang Q,Huang XE,Gao LL.Safety of pretreatment protocols of paclitaxel liposome[J].J China Pharm(中国药房),2009,20(11):841-843.
    [56]
    Shao CY,Li JP,Tu JS.In vitro stability of paclitaxel and docetaxel binary-drug loaded in micelles[J].J China Pharm Univ(中国药科大学学报),2010,41(5):428-434.
    • Related Articles

  • Related Articles

    [1]LI Yuchen, PAN Ziqian, XIAO Mengxue, ZHANG Yuanyuan. Advances in research on small intestinal injuries caused by nonsteroidal anti-inflammatory drugs and its prevention and treatment[J]. Journal of China Pharmaceutical University, 2023, 54(2): 150-158. DOI: 10.11665/j.issn.1000-5048.20220930001
    [2]YANG Nan, ZHANG Xiao, LYU Hui, HUO Meirong, XU Wei. Advances in immune checkpoint inhibitors combined with other treatments[J]. Journal of China Pharmaceutical University, 2023, 54(2): 131-140. DOI: 10.11665/j.issn.1000-5048.20221028002
    [3]LU Zhipeng, XU Qinglong, CHEN Panpan, QIN Yajuan, TANG Lijun, LI Tingyou. Research progress of radioprobes targeting fibroblast activating protein[J]. Journal of China Pharmaceutical University, 2022, 53(6): 651-662. DOI: 10.11665/j.issn.1000-5048.20220603
    [4]SHA Kang, LI Jiachen, QI Xiaole. Application and research progress of in situ gel for local treatment of periodontitis[J]. Journal of China Pharmaceutical University, 2022, 53(3): 365-375. DOI: 10.11665/j.issn.1000-5048.20220315
    [5]FENG Yang, XU Xiao, MO Ran. Advances in lymphatic targeted drug delivery system for treatment of tumor metastasis[J]. Journal of China Pharmaceutical University, 2020, 51(4): 425-432. DOI: 10.11665/j.issn.1000-5048.20200406
    [6]YANG Huizhen, MU Weiwei, LIU Yongjun, ZHANG Na. Research progress of drug delivery system based on black phosphorus in tumor diagnosis and treatment[J]. Journal of China Pharmaceutical University, 2020, 51(3): 270-276. DOI: 10.11665/j.issn.1000-5048.20200303
    [7]ZHANG Rui, JIANG Tao, ZENG Tianzhu, YAO Wenbing, GAO Xiangdong, TIAN Hong. Advances of combined immunotherapy in tumor[J]. Journal of China Pharmaceutical University, 2018, 49(4): 383-391. DOI: 10.11665/j.issn.1000-5048.20180401
    [8]DONG Xue, GU Yueqing. Application of optical molecular imaging technology in the diagnosis and treatment of diseases[J]. Journal of China Pharmaceutical University, 2014, 45(2): 145-152. DOI: 10.11665/j.issn.1000-5048.20140203
    [9]XU Yuhong, CAO Jing. Perspectives on targeted nano-drug carriers for tumor treatment[J]. Journal of China Pharmaceutical University, 2013, 44(6): 494-503. DOI: 10.11665/j.issn.1000-5048.20130602
    [10]Research Advances in the Targeting of Epidermal Growth Factor Receptor[J]. Journal of China Pharmaceutical University, 2004, (3): 91-94.

Catalog

    Get Citation
    PDF
    XML
    Article views (1500) PDF downloads (2798) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：278787

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return